Home
Overview
Research & Development
Investors
Press Releases
Employment
Contact
2010
Share Placement Completed
Share Placement
Genesis Research Suspends NZ Operations
SPP Documents
2009
Share Purchase Plan Oversubscribed
Letter to Shareholders
Genesis Research Establishes Solirna Biosciences
Share Purchase Plan Announcement
Letter to Shareholders 7 July 2009
Annual Meeting Presentation
Genesis Research Updates Funding Status
Funding Discussions
Genesis Confirms Focus on New Gene Silencing Technology with Significant Potential
Financial Statements and Statutory Information
2009 Full Year Results
Genesis Research Swaps Royalty Stream for Equity Stake
Letter to Shareholders
Genesis Research Announces Settlement Delay
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
2011
2012
2004
21.12.2004
GENESIS RESEARCH ANNOUNCES RESULTS OF PHASE II TRIAL OF AVAC™ IN CHILDHOOD
16.12.2004
GENESIS RESEARCH ANNOUNCES APPOINTMENT OF NEW CHIEF EXECUTIVE
21.11.2004
GENESIS RESEARCH ANNOUNCES RESULTS OF PARTNER'S PHASE II TRIAL
10.09.2004
DR PETER LEE TO LEAVE AGRIGENESIS
05.08.2004
GENESIS RESEARCH ANNOUNCES HALF YEAR RESULT
27.07.2004
GENESIS RESEARCH ANNOUNCES REDUCTION IN STAFF LEVELS
06.07.2004
SUCCESSFUL RECRUITMENT FOR PHASE II TRIAL OF AVAC™ IN CHILDHOOD ECZEMA
29.06.2004
MR J PALMER RESIGNS AS DIRECTOR OF GENESIS RESEARCH
10.06.2004
GENESIS RESEARCH ELECTS NEW CHAIRMAN
08.06.2004
GENESIS RESEARCH ANNUAL MEETING TUESDAY, 8 JUNE 2004: CHAIRMAN’S ADDRESS
08.06.2004
GENESIS RESEARCH ANNUAL MEETING TUESDAY, 8 JUNE 2004: CEO’S ADDRESS
08.06.2004
GENESIS RESEARCH ANNOUNCES RE-ELECTION OF DIRECTORS
31.03.2004
GENESIS RESEARCH ANNOUNCES RECRUITMENT MILESTONE FOR PHASE II TRIAL OF AVAC™
13.02.2004
GENESIS RESEARCH ANNOUNCES FULL YEAR RESULT
[Home]
